hotspot -WSS

hotspot

author：fashion 2025-10-01 15:31:06 - browse：82

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Akili changes sales model for its ADHD video game treatment

WSS

The strange history of BMI, the body mass index

Fed up with FDA, ALS advocates consider a take

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Why the quest to eradicate polio has stumbled

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

What happened to the House vote on health price transparency?

focus

hotspot

focus

In age of alternative facts, a scholarly course on calling out crap

Information blocking fines are now fair game in health care

Supreme Court strikes down use of affirmative action

White House Covid adviser calls on docs to combat misinformation

United colonoscopy coverage change 'may cost lives,' doctors say

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

How to save PrEP access — and even expand it

The strange history of BMI, the body mass index

Anesthesiologist group: stop taking Ozempic before surgery

'A game

hotspot

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

David Liu startup to focus on CRISPR delivery

PBMs drew scrutiny in House hearing — and so did pharma

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Illumina to lay off 10% of research and development team

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

hotspot

entertainment

entertainment

entertainment